174
Participants
Start Date
August 11, 2023
Primary Completion Date
July 30, 2029
Study Completion Date
July 30, 2029
VNZ/TEZ/D-IVA
Fixed-dose combination tablets or granules for oral administration.
Cohen Children's Medical Center - Lakeville Road, Lake Success
Children's Hospital of Pittsburgh - Pulmonology, Pittsburgh
The Emory Clinic - Clifton Road - Pulmonology, Atlanta
Nationwide Children's Hospital, Columbus
UH Cleveland Medical Center - Pulmonology, Cleveland
Cincinnati Children's Hospital Medical Center - Pulmonology, Cincinnati
JW Riley Hospital for Children - Pulmonology, Indianapolis
Children's Respiratory and Critical Care Specialists, P.A., Children's Hospitals and Clinics of Minnesota, Minneapolis
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
St. Louis Children's Hospital - Pulmonology, St Louis
The Children's Mercy Hospital, Kansas City
Texas Children's Hospital - Wallace Tower - Pulmonology, Houston
Children's Hospital of Colorado - Pulmonology, Aurora
Children's Hospital of Orange County, Orange
Stanford University - Palo Alto - Pulmonology, Palo Alto
Boston Children's Hospital, Boston
Vermont Lung Center, Colchester
American Family Childrens Hospital, Madison
Women & Children's Hospital, North Adelaide
Murdoch Children's Research Institute (MCRI) - Pulmonology, Parkville
Children's Health Queensland Hospital and Health Service, South Brisbane
Hopital Femme Mere-Enfant, Bron
Hopital Necker Enfants Malades - Pulmonology, Paris
Charite Paediatric Pulmonology Department, Berlin
Universitatsklinikum Essen, Essen
Medizinische Hochschule Hannover, Hanover
Sophia Children's Hospital, Rotterdam
Sahlgrenska Universitetssjukhuset - Göteborg CF-center, Gothenburg
Inselspital Bern, Bern
Kinderspital Zurich - Abteilung Pneumologie, Zurich
Noah's Ark Children's Hospital for Wales, Cardiff
Great Ormond Street Hospital for Children, London
Vertex Pharmaceuticals Incorporated
INDUSTRY